Biotec Pharma, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that two of its clinical supply experts will be participating in upcoming digital events, Clinical Trial Supply Europe and Clinical Trial Supply Roundtable Forum 2021.
As part of Clinical Trial Supply Europe Anna Munevver, Program Manager, Demand Led Supply will present at 10 a.m. CET on Thursday, March 25. Her talk, entitled “Harnessing Patient Demand to Gain Clinical Supply Flexibility and Efficiency,” will discuss the trend toward designing patient-centric clinical trials and how innovations in forecasting, supply pooling, decentralized packaging and labeling and demand-led supply can meet this goal, providing flexible and efficient trials.
On Tuesday, March 30, Our Director, Strategic Supply Solutions will participate in the one-day event, Clinical Trial Supply Roundtable Forum, and join a panel of experts to discuss “Direct to Patient Clinical Trials: A ‘Pharmerging’ Market”. The roundtable will run twice – once at 11 a.m., and again at 12 p.m. EST.
Ms. Munevver has 14 years’ experience in clinical supplies. In her current role, she is part of a global team which defines, develops and deploys innovative strategic supply chain solutions to increase efficiencies, reduce waste, improve patient access and reduce lead times for clinical supply provision. The team is responsible for programs including demand-led supply and direct-to-patient supply.
In her role at Biotec Pharma, Ms. Gulben is responsible for developing the company’s direct-to-patient business and other new strategic service offerings. She has 18 years’ experience in clinical supplies project management, and prior to her current role, spent six years as the Director of Project Management for Biotec’s Philadelphia facility. She is an active member of the Global Clinical Supplies Group (GCSG) and is currently the Board Secretary.
